课题基金 / 基金详情

Rehabilitation Engagement at Home with a socially Assistive roBot for Pediatric Adherence (REHAB-PAL)

Rehabilitation Engagement at Home with a socially Assistive roBot for Pediatric Adherence (REHAB-PAL)
使用社交辅助机器人在家进行儿科依从性康复 (REHAB-PAL)
批准号:
10325476
负责人:
Leonard Eusebi
金额:
$25.96万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-23 至 2023-08-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 脑性瘫痪(CP)是儿童最常见的运动障碍和致残原因,发病率较高 在美国大约有50万儿童。几乎所有患有脑瘫的儿童都要接受物理治疗 改善步态、力量、平衡或灵活性。这种疗法所依赖的剂量远远超过了临床可用的剂量。 治疗时间,使坚持居家治疗方案对成功至关重要。由于治疗可能很困难, 在儿科中保持参与度、坚持性、运动相关性和质量的重复,或只是不有趣 康复患者是有效的居家康复理疗方案的关键障碍。 为了促进参与度和忠诚度,解决方案必须具有吸引力和趣味性,与患者建立融洽的关系, 并在一次会议中促进集中注意力和纵向动机。活跃的视频游戏已被证明是一种 比典型做法有所改进,但仍有创新的空间;最近的研究表明, 基于人工智能、物理体现的社会代理的补充方法。通过激活 人类的自然社会反应,社交辅助机器人已被证明可以增强参与度和 在相关设置中遵守。 Charles River Analytics和我们在斯波尔丁康复医院的合作伙伴提议进行一期SBIR “家庭康复参与社会辅助机器人”的原型及可行性论证 儿科依从性“(rehab-pal)。Rehab-Pal是一款社交辅助机器人,适用于正在经历 在治疗期间提供陪伴和参与的康复性物理疗法。康复-PAL 通过鼓励有趣的处方治疗练习来提高对家庭护理方案的依从性 和支持性互动。为了严格地隔离它的影响,我们将把机器人与行为相似的 基于屏幕的虚拟代理。 我们将通过三个具体目标来原型和演示Rehab-PAL的可行性:(1)设计和开发 用于商业上可买到的小型类人机器人和基于屏幕的 虚拟代理。(2)整合视觉-运动整合任务。(3)评价康复仪的临床适宜性。 脑性瘫痪患儿的步态和平衡训练 最终,我们的目标是表明康复伙伴为患者提供了一个迷人和鼓舞人心的伴侣。 在整个可能乏味的治疗过程中,同时为临床医生提供了一种让儿科患者 激励并专注于他们的治疗,是提供连续性、一致性和监测的宝贵代理 在家庭护理期间。通过提高临床外治疗剂量的疗效,康复-PAL具有 有可能延长和改善护理,减少诊所就诊次数,提高依从性。
英文摘要
Project Summary/Abstract Cerebral Palsy (CP) is the most common motor disorder and cause of disability in children, with a prevalence of roughly half a million children in the United States. Nearly all children with CP undergo physical therapy to improve gait, strength, balance, or flexibility. This therapy depends on dosage far in excess of available clinical session time, making adherence to an at-home therapy regimen critical to success. As therapy may be difficult, repetitive, or just not fun, maintaining engagement, adherence, and exercise relevance and quality in pediatric rehabilitation patients are critical barriers to an effective at-home rehabilitative physical therapy regimen. To promote engagement and adherence, a solution must be attractive and fun, build rapport with the patient, and promote focus within a session as well as longitudinal motivation. Active video games have proven to be an improvement over typical practice but leave room for innovation; recent research suggests a promising complementary approach based on an artificially intelligent, physically embodied social agent. By activating humans’ natural social responses, socially assistive robots have been shown to enhance engagement and adherence in related settings. Charles River Analytics and our partners at Spaulding Rehabilitation Hospital propose a Phase I SBIR to prototype and demonstrate the feasibility of “Rehabilitation Engagement at Home with a socially Assistive roBot for Pediatric Adherence” (REHAB-PAL). REHAB-PAL is a socially assistive robot for children undergoing rehabilitative physical therapy that provides companionship and engagement during therapy. REHAB-PAL improves adherence to the home-care regimen by encouraging the prescribed therapeutic exercises with fun and supportive interaction. To rigorously isolate its effects, we will compare the robot to a behaviorally analogous screen-based virtual agent. We will prototype and demonstrate REHAB-PAL’s feasibility via three Specific Aims: (1) Design and develop socially assistive application software for a commercially available small humanoid robot and a screen-based virtual agent. (2) Integrate with a visuo-motor integration task. (3) Evaluate clinical suitability of REHAB-PAL for gait and balance training in children with CP. Ultimately, we aim to show that REHAB-PAL offers patients an engaging and encouraging companion throughout a potentially dreary treatment, while offering clinicians a superior tool to keep pediatric patients motivated and focused on their treatment and a valuable proxy to provide continuity, consistency and monitoring during home care. By enhancing the efficacy of therapeutic dosage outside the clinic, REHAB-PAL has the potential to extend and improve care, with less frequent clinic visits and improved adherence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金